Back

Incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: the single centre experience

19 May 2025 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Diagnosis and prognosis of HFpEF Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Milena Pandrc

Military Medical Academy of Belgrade, Belgrade (Serbia)

3 More presentations in this session

Presentation thumbnail
Frailty and cardiovascular comorbidities as predictors of short-term outcomes in HFpEF and HFmrEF patients: a retrospective cohort analysis
Associate Professor A. Briasoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Differences in heart failure with preserved ejection fraction diagnostic and therapeutic practices between physicians from europe and the middle east and north africa: an international survey
Professor H. Alarfaj (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Peroxiredoxin-4 and beta-hydroxybutyrate after SGLT2 inhibitor treatment in heart failure with preserved ejection fraction
Miss A. Achten (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and prognosis of HFpEF

The Event

Event poster

Heart Failure 2025

19 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
The rhythm control strategy in patients with atrial fibrillation and heart failure with preserved or reduced ejection fraction: the single centre experience
thumbnail
Congress Presentation
Characterizing atrial fibrillation in patients with and without heart failure and across the ejection fraction spectrum: incidence, prevalence, and treatment strategies
thumbnail
Congress Presentation
The interplay of atrial fibrillation and heart failure: a quest for causality

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources